Application and Selection Process
The 2025 EOI Period is now closed.
Application Timeline Overview
Application Review and Selection Process
Assessment is conducted by an independent Investment Review Committee (IRC), composed of nationally and internationally recognised experts in vaccine and therapeutic product development, infectious diseases, pre-clinical and clinical development, regulatory affairs and manufacturing process development. IRC recommendations are endorsed by the Biointelect Venturer Steering Committee, before approval by the Biointelect Board, ensuring a rigorous, transparent and fair decision-making process.
Applications are evaluated through a structured, multi-stage process:
1. Expression of Interest (EOI)
Applicants submit a non-confidential EOI via the Biointelect Venturer application portal. EOIs are screened for eligibility by the Biointelect Venturer team and assessed for scientific and commercial merit by representative members of the Investment Review Committee (IRC). Shortlisted EOIs are endorsed by the Steering Committee, approved by the Biointelect Board and invited to submit a full application. Feedback is provided to shortlisted applicants.
2. Full Application
Shortlisted applicants are invited to submit a full application that addresses feedback from the EOI stage and provides a detailed project plan, commercialisation strategy, risk management plan and budget. The IRC assesses full applications and recommends a shortlist for due diligence review.
3. Due Diligence
The Biointelect Venturer team undertakes verification of IP ownership, financials and business structure, and identifies potential risks. Applications and associated due diligence reports are endorsed by the Steering Committee.
4. Interview
Top-ranked applicants are invited to present their project to an interview panel comprising representatives of the Biointelect Venturer team, the IRC and the Steering Committee. The interview assesses applicants’ ability to address identified risks and their overall suitability for incubation.
5. Final Selection
Funding recommendations are finalised by the interview panel and endorsed by the Steering Committee before approval by the Biointelect Board for contracting.
For further information on application and review process, please refer to the Funding Guidelines.
For any queries about your application, email: venturer@biointelect.com.
